AYTU
Aytu Biopharma, Inc
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
No thesis.
Aytu Biopharma, Inc
1.98
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Stonepine Capital ManagementStonepine | $10.7M | 63.06% | +529.85% | |
| 2 | Nantahala Capital ManagementNantahala | $2.3M | 13.73% | 0.00% | |
| 3 | AWM InvestmentAWM Investment | $1.3M | 7.83% | 0.00% | |
| 4 | Vanguard Capital ManagementVanguardindex-like | $561,464 | 3.30% | 0.00% | |
| 5 | Crown Advisors ManagementCrown | $430,000 | 2.53% | +37.93% | |
| 6 | Diadema PartnersDiadema Partners | $319,374 | 1.88% | −57.93% | |
| 7 | Two Sigma InvestmentsTwo Sigma | $226,451 | 1.33% | −13.65% | |
| 8 | Renaissance TechnologiesRenaissance Technologies | $225,369 | 1.32% | +11.84% | |
| 9 | Geode Capital ManagementGeodeindex-like | $201,371 | 1.18% | +1.09% | |
| 10 | Citadel AdvisorsCitadel | $106,240 | 0.62% | +34.13% | |
| 11 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $101,153 | 0.59% | 0.00% | |
| 12 | Dimensional Fund AdvisorsDimensional | $97,451 | 0.57% | +3.99% | |
| 13 | Persistent Asset PartnersPersistent Asset Partners | $81,666 | 0.48% | −59.11% | |
| 14 | Northern TrustNorthern Trustindex-like | $60,039 | 0.35% | +45.68% | |
| 15 | Bellevue Asset ManagementBellevue | $53,777 | 0.32% | 0.00% | |
| 16 | BlackRockBlackRockindex-like | $49,005 | 0.29% | 0.00% | |
| 17 | XTX TopcoXTX Topco | $46,044 | 0.27% | −0.77% | |
| 18 | Daytona Street CapitalDaytona Street Capital | $22,350 | 0.13% | 0.00% | |
| 19 | Acadian Asset ManagementAcadian | $22,000 | 0.13% | 0.00% | |
| 20 | UBS GroupUBS | $5,110 | 0.03% | +42.93% | |
| 21 | Tower Research Capital LLC (TRC)Tower Research Capital LLC (TRC) | $4,799 | 0.03% | +42.71% | |
| 22 | Royal Bank of CanadaRoyal Bank of Canada | $1,000 | 0.01% | +950.00% | |
| 23 | Advisor Group HoldingsAdvisor | $991 | 0.01% | 0.00% | |
| 24 | JPMorgan ChaseJPMorgan Chase | $337 | 0.00% | 0.00% | |
| 25 | Wells FargoWells Fargo | $273 | 0.00% | 0.00% |
35 managers report $17.0M of Aytu Biopharma on form 13F for the quarter ended Jun 30 '26. 3 of them hold 80% of it; Stonepine is largest at 63.06%.
No implied move.
No implied move.
Expected move
No implied move.